Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized pilot phase I trial studies the side effects of dietary fat levels and
abiraterone acetate uptake in patients with metastatic hormone-resistant prostate cancer.
Abiraterone acetate may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth. Eating a low or high fat diet may increase the uptake of abiraterone
acetate.